Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Full article: Chemokine receptor antagonists: Part 1
Sander G Mills's research works Merck & Co., Whitehouse Station (MSD) and other places
Full article: Chemokine receptor antagonists: Part 1
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists - ScienceDirect
Full article: Future therapeutic treatment of COPD: Struggle between oxidants and cytokines
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
Pharmaceuticals, Free Full-Text
Structural Analysis of Chemokine Receptor-Ligand Interactions. - Abstract - Europe PMC
Full article: Chemokine receptor antagonists: Part 1
de
por adulto (o preço varia de acordo com o tamanho do grupo)
